Tempest Therapeutics Inc (TPST)
3.18
-0.04
(-1.24%)
USD |
NASDAQ |
May 17, 16:00
3.18
0.00 (0.00%)
After-Hours: 20:00
Tempest Therapeutics 1 Year Total Returns (Daily): 55.88% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 17, 2024 | 55.88% |
May 16, 2024 | 58.62% |
May 15, 2024 | 55.05% |
May 14, 2024 | 61.90% |
May 13, 2024 | 56.19% |
May 10, 2024 | 57.77% |
May 09, 2024 | 69.27% |
May 08, 2024 | 69.27% |
May 07, 2024 | 76.59% |
May 06, 2024 | 81.95% |
May 03, 2024 | 84.50% |
May 02, 2024 | 64.65% |
May 01, 2024 | 64.55% |
April 30, 2024 | 63.68% |
April 29, 2024 | 62.26% |
April 26, 2024 | 96.67% |
April 25, 2024 | 80.31% |
April 24, 2024 | 62.26% |
April 23, 2024 | 49.34% |
April 22, 2024 | 41.48% |
April 19, 2024 | 31.91% |
April 18, 2024 | 43.44% |
April 17, 2024 | -11.62% |
April 16, 2024 | 13.56% |
April 15, 2024 | 13.22% |
Date | Value |
---|---|
April 12, 2024 | -4.52% |
April 11, 2024 | 10.95% |
April 10, 2024 | 40.38% |
April 09, 2024 | 59.26% |
April 08, 2024 | 64.20% |
April 05, 2024 | 59.23% |
April 04, 2024 | 95.65% |
April 03, 2024 | 125.8% |
April 02, 2024 | 119.4% |
April 01, 2024 | 134.5% |
March 28, 2024 | 123.4% |
March 27, 2024 | 170.3% |
March 26, 2024 | 172.8% |
March 25, 2024 | 167.6% |
March 22, 2024 | 177.0% |
March 21, 2024 | 176.4% |
March 20, 2024 | 198.4% |
March 19, 2024 | 209.1% |
March 18, 2024 | 219.8% |
March 15, 2024 | 188.9% |
March 14, 2024 | 159.8% |
March 13, 2024 | 197.4% |
March 12, 2024 | 170.4% |
March 11, 2024 | 170.4% |
March 08, 2024 | 128.3% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-93.09%
Minimum
Mar 15 2022
510.6%
Maximum
Oct 11 2023
-36.73%
Average
-55.51%
Median
Oct 25 2021
1 Year Total Returns (Daily) Benchmarks
CEL-SCI Corp | -52.96% |
AIM ImmunoTech Inc | -19.40% |
IGC Pharma Inc | 69.70% |
NovaBay Pharmaceuticals Inc | -83.53% |
Protalix BioTherapeutics Inc | -51.69% |